Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 26;11(9):1918-1929.
doi: 10.12998/wjcc.v11.i9.1918.

COVID-19 related liver injuries in pregnancy

Affiliations
Review

COVID-19 related liver injuries in pregnancy

Metodija Sekulovski et al. World J Clin Cases. .

Abstract

While severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) quickly spread across the globe, our understanding of its pathogenic mechanisms evolved. Importantly, coronavirus disease 2019 (COVID-19) is now considered a syndromic multisystem inflammatory disease involving not only the respiratory system but also the cardiovascular, excretory, nervous, musculoskeletal, and gastrointestinal systems. Moreover, a membrane-bound form of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2, is expressed on the surface of cholangiocytes and hepatocytes, suggesting the potential of COVID-19 to involve the liver. With the widespread distribution of SARS-CoV-2 throughout the population, infection during pregnancy is no longer a rare occurrence; however, little is known about the course of hepatic injuries and related outcomes in pregnant SARS-CoV-2-positive women. Thus, the understudied topic of COVID-related liver disease during pregnancy poses a great challenge for the consulting gynecologist and hepatologist. In this review, we aim to describe and summarize potential liver injuries in pregnant women with COVID-19.

Keywords: Angiotensin-converting enzyme 2 receptors; COVID-19; Liver injury; Pregnancy; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare they have no conflicts of interest.

Figures

Figure 1
Figure 1
Severe coronavirus disease 2019 in pregnancy and associated complications for mother and fetus. COVID-19: Coronavirus disease 2019; HELLP: Hemolysis, elevated liver enzymes, low platelets; HIV: Human immunodeficiency virus.

References

    1. World Health Organization. Weekly epidemiological update on COVID-19 - 21 December 2022. [cited 4 January 2023]. Available from: https://www.who.int/publications/m/item/covid-19-weekly-epidemiological-... .
    1. Georgiev T, Angelov AK. Complexities of diagnosis and management of COVID-19 in autoimmune diseases: Potential benefits and detriments of immunosuppression. World J Clin Cases. 2020;8:3669–3678. - PMC - PubMed
    1. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271–280.e8. - PMC - PubMed
    1. Velikova T, Snegarova V, Kukov A, Batselova H, Mihova A, Nakov R. Gastrointestinal mucosal immunity and COVID-19. World J Gastroenterol. 2021;27:5047–5059. - PMC - PubMed
    1. Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, Zhou J, Shi G, Fang N, Fan J, Cai J, Lan F. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. 2020 Preprint. Available from: bioRxiv:2020.02.03.931766.